Suchergebnisse - "Gavande, Navnath S."

PubPharm (27)

1

Compositions and methods relating to inhibitors of pro-inflammatory factors for treatment of cancer

enthalten in: Europäisches Patentamt | 2024

von POWELL ISAAC J | GAVANDE NAVNATH S

2

Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy

enthalten in: Drug discovery today | 2023

von Bhise, K. | Gavande, N. | Iyer, A.

3

Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Parajuli, P. | Rosati, R. | Mamdani, H. | +7

4

PROTAC'ing oncoproteins : targeted protein degradation for cancer therapy

enthalten in: Molecular cancer | 2023

von Kelm, J. | Pandey, D. | Malin, E. | +4

5

Targeting the Epidermal Growth Factor Receptor with Molecular Degraders : State-of-the-Art and Future Opportunities

enthalten in: Journal of medicinal chemistry | 2023

von Maity, P. | Chatterjee, J. | Patil, K. | +9

6

Ku-DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks

enthalten in: NAR cancer | 2023

von Mendoza-Munoz, P. | Gavande, N. | VanderVere-Carozza, P. | +4

7

COMPOSITIONS AND METHODS RELATING TO INHIBITORS OF PRO-INFLAMMATORY FACTORS FOR TREATMENT OF CANCER

enthalten in: Europäisches Patentamt | 2023

von POWELL ISAAC J | GAVANDE NAVNATH S

8

COMPOSITIONS AND METHODS RELATING TO INHIBITORS OF PRO-INFLAMMATORY FACTORS FOR TREATMENT OF CANCER

enthalten in: Europäisches Patentamt | 2023

von POWELL ISAAC J | GAVANDE NAVNATH S

9

Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes

enthalten in: Cancer immunology immunotherapy | 2022

von Parajuli, P. | Rosati, R. | Mamdani, H. | +7

10

Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes

enthalten in: Cancer immunology immunotherapy | 2022

von Parajuli, P. | Rosati, R. | Mamdani, H. | +7